Jeffrey Raizer MD

Clinical Trials

• Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma Start of enrollment: 1999 Dec 01

  Completed

  Phase 1

• Taurolidine in Treating Patients With Recurrent or Progressive Glioma Start of enrollment: 2001 May 01

  Completed

  Phase 1

• Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery Start of enrollment: 2005 May 01

  Active, not recruiting

  Phase 1, Phase 2

• Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases Start of enrollment: 2005 Nov 01

  Active, not recruiting

  Phase 2

• Bevacizumab in Treating Patients With Recurrent or Progressive Glioma Start of enrollment: 2006 Mar 01

  Completed

  Phase 2

• Vatalanib in Treating Patients With Recurrent or Progressive Meningioma Start of enrollment: 2006 May 01

  Completed

  Phase 2

• 131-I-TM-601 Study in Adults With Solid Tumors Start of enrollment: 2006 Aug 01

  Completed

  Phase 1

• AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2006 Oct 01

  Unknown status

  Phase 1, Phase 2

• Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases Start of enrollment: 2007 Feb 01

  Withdrawn

  Not Applicable

• Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases Start of enrollment: 2007 Jan 01

  Completed

  Early Phase 1

• VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma Start of enrollment: 2007 Aug 01

  Terminated

  Phase 1

• A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01

  Unknown status

  Phase 1, Phase 2

• Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Start of enrollment: 2009 Jul 07

  Completed

  Phase 2

• Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL Start of enrollment: 2008 Nov 01

  Withdrawn

  Early Phase 1

• Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide Start of enrollment: 2009 May 01

  Completed

  Phase 2

• Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma Start of enrollment: 2009 Dec 01

  Unknown status

  Phase 2

• Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy Start of enrollment: 2012 Feb 01

  Completed

  Phase 1, Phase 2

• Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer Start of enrollment: 2011 Aug 01

  Completed

  Phase 1, Phase 2

• Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Start of enrollment: 2011 Sep 01

  Completed

  Phase 2

• Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas Start of enrollment: 2011 Dec 14

  Terminated

  Phase 2

• Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2011 Nov 01

  Completed

  Phase 3

• Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2012 Dec 20

  Completed

  Phase 2

• A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2013 Jul 18

  Completed

  Phase 1, Phase 2

• Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Start of enrollment: 2013 Jun 19

  TERMINATED

  PHASE2

• Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy Start of enrollment: 2013 Nov 27

  Completed

  Phase 2

• Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2014 Feb 28

  Completed

  Phase 1

• A Phase 2 Study of BGJ398 in Patients With Recurrent GBM Start of enrollment: 2013 Dec 09

  Completed

  Phase 2

• Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme

  COMPLETED

  PHASE1, PHASE2

• Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma Start of enrollment: 2016 Nov 01

  Completed

  Phase 2

• Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer Start of enrollment: 2017 Jan 01

  Terminated

  Phase 1

• Join now to see all